Steve Finkbeiner, MD, PhD
Professor
Neurology
School of Medicine
steven.finkbeiner@ucs.eu 415-734-2508
Areas of Investigation: Research in our laboratory focuses on molecular mechanisms of plasticity and neurodegeneration. A long-term goal of our research is to understand how neuronal activity elicits changes in gene expression that are important for learning and memory. We also aim to understand how an inherited genetic mutation leads to neuronal dysfunction and degeneration in Huntington’s disease (HD).
Show full bio (460 words) Hide full bio
Significance: To convert brief experiences into long-term memories, new gene expression is needed. Understanding how brief neuronal activity regulates gene expression could help us understand how memories are formed. We may also develop new strategies to help people with cognitive disturbances such as those seen in HD. HD is the most common inherited neurodegenerative disorder and belongs to a family of 12 neurological diseases, which are caused by the same type of mutation an abnormal expansion of a homomeric polyglutamine stretch within the affected protein.
Approaches We use cellular, molecular, biochemical, imaging, and electrophysiological approaches to elucidate the molecular mechanisms of plasticity and neurodegeneration. We have developed primary culture models of activity-dependent gene transcription and of HD. These models faithfully recapitulate critical features of these processes and allow us to test hypotheses about their underlying mechanisms. Selected findings are evaluated further in genetically modified mice.
Contributions: We have contributed to the understanding of mechanisms of plasticity and neurodegeneration in several ways. We found that proteins bound to the cytoplasmic portion of one subtype of glutamate receptor, the N-methyl-D-aspartate receptor, play a critical role coupling local Ca2+ influx through the channel to elicit adaptive gene transcription in neurons. This may be a general mechanism by which diverse Ca2+ channels achieve specific and distinct neuronal responses. We developed a neuronal model that faithfully recapitulates key features of HD. We showed that the nucleus is a critical subcellular site in which mutant huntingtin (the affected protein in HD) induces neurodegeneration. However, mutant huntingtin need not aggregate into inclusions to induce neurodegeneration. Recently, we developed a new automated imaging system that we call a robotic microscope. The instrument enables us to track living neurons over long time periods and to, quantify quickly the adaptive or maladaptive responses of thousands of neurons. Along with special statistical methods, we now have the ability to determine whether and to what extent a variable that is observed on one day can predict the fate of that neuron on another day. This ability will enable us to unravel confounding cause-and-effect mechanisms.
Questions Addressed in Ongoing Studies
- How does the C-terminus of the NMDA receptor couple Ca2+ influx to gene expression?
- What are the gene targets of the NMDA receptor and to what extent do they differ from gene targets of other neuronal - Ca2+ channels?
- What role does subsynaptic protein translation play in synapse-specific gene expression, learning, and memory?
- How does the polyglutamine expansion induce selective degeneration in certain types of neurons?
- What roles do ubiquitination and proteasome function play in neurodegeneration?
- What is the normal function of huntingtin?
- Which is a better predictor of neurodegeneration inclusion body formation or more soluble but malfolded versions of huntingtin?
Education & Training
Show all (3) Hide
- Diversity, Equity, Inclusion Champion Training UCSF 08/2021
- Neurology UCSF 05/1995
- MD/PhD Medicine and Neuroscience Yale University 05/1991
Publications (172)
Top publication keywords:
Huntington DiseaseAmyotrophic Lateral SclerosisHuntingtin ProteinInduced Pluripotent Stem CellsAutophagyCytoskeletal ProteinsMotor NeuronsNeuronsCell DeathNeurodegenerative DiseasesInclusion BodiesLysosomesNeuronal PlasticityNerve Tissue ProteinsPeptides
-
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.
Cell reports 2025 Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan Ú, Mauna JC, Mack KL, Class B, Ollerhead TA, Ford AF, Barbieri EM, Cupo RR, Drake LE, Smalley JL, Lin YT, Lam S, Thomas R, Castello N, Baral A, Beyer JN, Najar… -
Generalizable Prediction of Alzheimer Disease Pathologies with a Scalable Annotation Tool and an High-Accuracy Model.
medRxiv : the preprint server for health sciences 2025 Gopal Ramaswamy V, Ahirwar M, Ryan G, Dugger BN, Al Dalahmah O, Signaevsky M, Purohit DP, Haroutunian V, Finkbeiner S -
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy.
Cell reports 2025 Aikio M, Odeh HM, Wobst HJ, Lee BL, Chan Ú, Mauna JC, Mack KL, Class B, Ollerhead TA, Ford AF, Barbieri EM, Cupo RR, Drake LE, Smalley JL, Lin YT, Lam S, Thomas R, Castello N, Baral A, Beyer JN, Najar… -
Huntingtin contains an ubiquitin-binding domain and regulates lysosomal targeting of mitochondrial and RNA-binding proteins.
Proceedings of the National Academy of Sciences of the United States of America 2024 Fote GM, Eapen VV, Lim RG, Yu C, Salazar L, McClure NR, McKnight J, Nguyen TB, Heath MC, Lau AL, Villamil MA, Miramontes R, Kratter IH, Finkbeiner S, Reidling JC, Paulo JA, Kaiser P, Huang L, Housman … -
A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
Science advances 2024 Bansal P, Banda EC, Glatt-Deeley HR, Stoddard CE, Linsley JW, Arora N, Deleschaux C, Ahern DT, Kondaveeti Y, Massey RE, Nicouleau M, Wang S, Sabariego-Navarro M, Dierssen M, Finkbeiner S, Pinter SF
Show all (167 more) Hide
-
Three dimensional and four dimensional live imaging to study mechanisms of progressive neurodegeneration.
The Journal of biological chemistry 2024 Linsley JW, Reisine T, Finkbeiner S -
Disease related changes in ATAC-seq of iPSC-derived motor neuron lines from ALS patients and controls.
Nature communications 2024 Tsitkov S, Valentine K, Kozareva V, Donde A, Frank A, Lei S, Answer ALS Consortium, E Van Eyk J, Finkbeiner S, Rothstein JD, Thompson LM, Sareen D, Svendsen CN, Fraenkel E -
A Trisomy 21-linked Hematopoietic Gene Variant in Microglia Confers Resilience in Human iPSC Models of Alzheimer's Disease.
bioRxiv : the preprint server for biology 2024 Jin M, Ma Z, Dang R, Zhang H, Kim R, Xue H, Pascual J, Finkbeiner S, Head E, Liu Y, Jiang P -
A foundational atlas of autism protein interactions reveals molecular convergence.
bioRxiv : the preprint server for biology 2024 Wang B, Vartak R, Zaltsman Y, Naing ZZC, Hennick KM, Polacco BJ, Bashir A, Eckhardt M, Bouhaddou M, Xu J, Sun N, Lasser MC, Zhou Y, McKetney J, Guiley KZ, Chan U, Kaye JA, Chadha N, Cakir M, Gordon M,… -
Enhancing Spatial Transcriptomics Analysis by Integrating Image-Aware Deep Learning Methods.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 2024 Song J, Lamstein J, Ramaswamy VG, Webb M, Zada G, Finkbeiner S, Craig DW -
A Comprehensive Enumeration of the Human Proteostasis Network. 2. Components of the Autophagy-Lysosome Pathway.
bioRxiv : the preprint server for biology 2023 Elsasser S, Elia LP, Morimoto RI, Powers ET, Finley D, Costa B, Budron M, Tokuno Z, Wang S, Iyer RG, Barth B, Mockler E, Finkbeiner S, Gestwicki JE, Richardson RAK, Stoeger T, Tan EP, Xiao Q, Cole CM,… -
AutoComet: A fully automated algorithm to quickly and accurately analyze comet assays.
Redox biology 2023 Barbé L, Lam S, Holub A, Faghihmonzavi Z, Deng M, Iyer R, Finkbeiner S -
Large-scale differentiation of iPSC-derived motor neurons from ALS and control subjects.
Neuron 2023 Workman MJ, Lim RG, Wu J, Frank A, Ornelas L, Panther L, Galvez E, Perez D, Meepe I, Lei S, Valencia V, Gomez E, Liu C, Moran R, Pinedo L, Tsitkov S, Ho R, Kaye JA, Answer ALS Consortium, Thompson T, … -
The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism.
Cell genomics 2023 Bressan E, Reed X, Bansal V, Hutchins E, Cobb MM, Webb MG, Alsop E, Grenn FP, Illarionova A, Savytska N, Violich I, Broeer S, Fernandes N, Sivakumar R, Beilina A, Billingsley KJ, Berghausen J, … -
Frontotemporal Dementia Patient Neurons With Progranulin Deficiency Display Protein Dyshomeostasis.
bioRxiv : the preprint server for biology 2023 Elia L, Herting B, Alijagic A, Buselli C, Wong L, Morrison G, Prado MA, Paulo JA, Gygi SP, Finley D, Finkbeiner S -
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotency.
Scientific data 2023 Matlock AD, Vaibhav V, Holewinski R, Venkatraman V, Dardov V, Manalo DM, Shelley B, Ornelas L, Banuelos M, Mandefro B, Escalante-Chong R, Li J, Finkbeiner S, Fraenkel E, Rothstein J, Thompson L, … -
Nuclear accumulation of host transcripts during Zika Virus Infection.
PLoS pathogens 2023 Leon KE, Khalid MM, Flynn RA, Fontaine KA, Nguyen TT, Kumar GR, Simoneau CR, Tomar S, Jimenez-Morales D, Dunlap M, Kaye J, Shah PS, Finkbeiner S, Krogan NJ, Bertozzi C, Carette JE, Ott M -
Fluorescently labeled nuclear morphology is highly informative of neurotoxicity.
Frontiers in toxicology 2022 Wang S, Linsley JW, Linsley DA, Lamstein J, Finkbeiner S -
Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.
Faculty reviews 2022 Kaye J, Reisine T, Finkbeiner S -
Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases.
Frontiers in aging neuroscience 2022 Barbé L, Finkbeiner S -
Generation of two human induced pluripotent stem cell lines from fibroblasts of Parkinson's disease patients carrying the ILE368ASN mutation in PINK1 (LCSBi002) and the R275W mutation in Parkin (LCSBI004).
Stem cell research 2022 Novak G, Finkbeiner S, Skibinski G, Bernini M, Donato C, Skupin A -
The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity.
The Journal of cell biology 2022 Stormo AED, Shavarebi F, FitzGibbon M, Earley EM, Ahrendt H, Lum LS, Verschueren E, Swaney DL, Skibinski G, Ravisankar A, van Haren J, Davis EJ, Johnson JR, Von Dollen J, Balen C, Porath J, Crosio C, … -
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines.
Nature neuroscience 2022 Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, Ramamoorthy D, Lima L, Vaibhav V, Matlock A, Frank A, Coyne AN, Landin B, Ornelas L, Mosmiller E, Thrower S, Farr SM, Panther L, Gomez E, Galvez E, … -
Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson's disease.
Communications biology 2022 Novak G, Kyriakis D, Grzyb K, Bernini M, Rodius S, Dittmar G, Finkbeiner S, Skupin A -
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.
The Journal of clinical investigation 2022 Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L, Finkbeiner S, Huang EJ, Jr RVF -
Superhuman cell death detection with biomarker-optimized neural networks.
Science advances 2021 Linsley JW, Linsley DA, Lamstein J, Ryan G, Shah K, Castello NA, Oza V, Kalra J, Wang S, Tokuno Z, Javaherian A, Serre T, Finkbeiner S -
Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson's disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007).
Stem cell research 2021 Novak G, Finkbeiner S, Skibinski G, Skupin A -
Huntington's disease mouse models: unraveling the pathology caused by CAG repeat expansion.
Faculty reviews 2021 Kaye J, Reisine T, Finkbeiner S -
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients.
iScience 2021 NeuroLINCS Consortium, Li J, Lim RG, Kaye JA, Dardov V, Coyne AN, Wu J, Milani P, Cheng A, Thompson TG, Ornelas L, Frank A, Adam M, Banuelos MG, Casale M, Cox V, Escalante-Chong R, Daigle JG, Gomez E,… -
Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson's patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006).
Stem cell research 2021 Novak G, Finkbeiner S, Skibinski G, Skupin A -
Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched.
Stem cell research 2021 Reed X, Cobb MM, Skinbinski G, Roosen D, Kaganovich A, Ding J, Finkbeiner S, Cookson MR -
Persistent mRNA localization defects and cell death in ALS neurons caused by transient cellular stress.
Cell reports 2021 Markmiller S, Sathe S, Server KL, Nguyen TB, Fulzele A, Cody N, Javaherian A, Broski S, Finkbeiner S, Bennett EJ, Lécuyer E, Yeo GW -
Genetically encoded cell-death indicators (GEDI) to detect an early irreversible commitment to neurodegeneration.
Nature communications 2021 Linsley JW, Shah K, Castello N, Chan M, Haddad D, Doric Z, Wang S, Leks W, Mancini J, Oza V, Javaherian A, Nakamura K, Kokel D, Finkbeiner S -
Longitudinal tracking of neuronal mitochondria delineates PINK1/Parkin-dependent mechanisms of mitochondrial recycling and degradation.
Science advances 2021 Li H, Doric Z, Berthet A, Jorgens DM, Nguyen MK, Hsieh I, Margulis J, Fang R, Debnath J, Sesaki H, Finkbeiner S, Huang E, Nakamura K -
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
The Journal of clinical investigation 2021 Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai LH, Huang EJ -
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Autophagy 2021 Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, … -
Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease.
Neurobiology of disease 2020 Finkbeiner S -
Publisher Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
Nature communications 2020 Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Oliveira AO, Wong JS, Daub AC, Giorgini F, Muchowski P, Finkbeiner S -
The Autophagy Lysosomal Pathway and Neurodegeneration.
Cold Spring Harbor perspectives in biology 2020 Finkbeiner S -
Author Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
Nature communications 2020 Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Osório Oliveira A, Wong JS, Daub AC, Giorgini F, Muchowski P, Finkbeiner S -
Approaches to develop therapeutics to treat frontotemporal dementia.
Neuropharmacology 2020 Elia LP, Reisine T, Alijagic A, Finkbeiner S -
Small-Molecule Modulation of TDP-43 Recruitment to Stress Granules Prevents Persistent TDP-43 Accumulation in ALS/FTD.
Neuron 2019 Fang MY, Markmiller S, Vu AQ, Javaherian A, Dowdle WE, Jolivet P, Bushway PJ, Castello NA, Baral A, Chan MY, Linsley JW, Linsley D, Mercola M, Finkbeiner S, Lecuyer E, Lewcock JW, Yeo GW -
Cell death assays for neurodegenerative disease drug discovery.
Expert opinion on drug discovery 2019 Linsley JW, Reisine T, Finkbeiner S -
Automated four-dimensional long term imaging enables single cell tracking within organotypic brain slices to study neurodevelopment and degeneration.
Communications biology 2019 Linsley JW, Tripathi A, Epstein I, Schmunk G, Mount E, Campioni M, Oza V, Barch M, Javaherian A, Nowakowski TJ, Samsi S, Finkbeiner S -
Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2019 Elia LP, Mason AR, Alijagic A, Finkbeiner S -
The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid Protein.
mBio 2018 Fontaine KA, Leon KE, Khalid MM, Tomar S, Jimenez-Morales D, Dunlap M, Kaye JA, Shah PS, Finkbeiner S, Krogan NJ, Ott M -
Publisher Correction: Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
Nature communications 2018 Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Wong JS, Daub AC, Giorgini F, Finkbeiner S -
Deubiquitinase Usp12 functions noncatalytically to induce autophagy and confer neuroprotection in models of Huntington's disease.
Nature communications 2018 Aron R, Pellegrini P, Green EW, Maddison DC, Opoku-Nsiah K, Oliveira AO, Wong JS, Daub AC, Giorgini F, Muchowski P, Finkbeiner S -
The Psychiatric Cell Map Initiative: A Convergent Systems Biological Approach to Illuminating Key Molecular Pathways in Neuropsychiatric Disorders.
Cell 2018 Willsey AJ, Morris MT, Wang S, Willsey HR, Sun N, Teerikorpi N, Baum TB, Cagney G, Bender KJ, Desai TA, Srivastava D, Davis GW, Doudna J, Chang E, Sohal V, Lowenstein DH, Li H, Agard D, Keiser MJ, … -
The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease.
Seminars in cell & developmental biology 2018 Epstein I, Finkbeiner S -
In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images.
Cell 2018 Christiansen EM, Yang SJ, Ando DM, Javaherian A, Skibinski G, Lipnick S, Mount E, O'Neil A, Shah K, Lee AK, Goyal P, Fedus W, Poplin R, Esteva A, Berndl M, Rubin LL, Nelson P, Finkbeiner S -
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
Neuron 2018 Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ, Nalls MA, Keagle P, Rivera AM, van Rheenen W, Murphy NA, van Vugt JJFA, Geiger JT, Van der Spek RA, Pliner HA, Smith … -
Assessing microscope image focus quality with deep learning.
BMC bioinformatics 2018 Yang SJ, Berndl M, Michael Ando D, Barch M, Narayanaswamy A, Christiansen E, Hoyer S, Roat C, Hung J, Rueden CT, Shankar A, Finkbeiner S, Nelson P -
iPS cells in the study of PD molecular pathogenesis.
Cell and tissue research 2017 Cobb MM, Ravisankar A, Skibinski G, Finkbeiner S -
Huntingtin Inclusions Trigger Cellular Quiescence, Deactivate Apoptosis, and Lead to Delayed Necrosis.
Cell reports 2017 Ramdzan YM, Trubetskov MM, Ormsby AR, Newcombe EA, Sui X, Tobin MJ, Bongiovanni MN, Gras SL, Dewson G, Miller JML, Finkbeiner S, Moily NS, Niclis J, Parish CL, Purcell AW, Baker MJ, Wilce JA, Waris S,… -
Egocentric and allocentric visuospatial working memory in premotor Huntington's disease: A double dissociation with caudate and hippocampal volumes.
Neuropsychologia 2017 Possin KL, Kim H, Geschwind MD, Moskowitz T, Johnson ET, Sha SJ, Apple A, Xu D, Miller BL, Finkbeiner S, Hess CP, Kramer JH -
The Receptor-interacting Serine/Threonine Protein Kinase 1 (RIPK1) Regulates Progranulin Levels.
The Journal of biological chemistry 2017 Mason AR, Elia LP, Finkbeiner S -
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.
Proceedings of the National Academy of Sciences of the United States of America 2016 Skibinski G, Hwang V, Ando DM, Daub A, Lee AK, Ravisankar A, Modan S, Finucane MM, Shaby BA, Finkbeiner S -
Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington's disease pathology.
Human molecular genetics 2016 Mao Y, Chen X, Xu M, Fujita K, Motoki K, Sasabe T, Homma H, Murata M, Tagawa K, Tamura T, Kaye J, Finkbeiner S, Blandino G, Sudol M, Okazawa H -
Protein-RNA Networks Regulated by Normal and ALS-Associated Mutant HNRNPA2B1 in the Nervous System.
Neuron 2016 Martinez FJ, Pratt GA, Van Nostrand EL, Batra R, Huelga SC, Kapeli K, Freese P, Chun SJ, Ling K, Gelboin-Burkhart C, Fijany L, Wang HC, Nussbacher JK, Broski SM, Kim HJ, Lardelli R, Sundararaman B, … -
Identification of hepta-histidine as a candidate drug for Huntington's disease by in silico-in vitro- in vivo-integrated screens of chemical libraries.
Scientific reports 2016 Imamura T, Fujita K, Tagawa K, Ikura T, Chen X, Homma H, Tamura T, Mao Y, Taniguchi JB, Motoki K, Nakabayashi M, Ito N, Yamada K, Tomii K, Okano H, Kaye J, Finkbeiner S, Okazawa H -
Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
The Journal of clinical investigation 2016 Kratter IH, Zahed H, Lau A, Tsvetkov AS, Daub AC, Weiberth KF, Gu X, Saudou F, Humbert S, Yang XW, Osmand A, Steffan JS, Masliah E, Finkbeiner S -
SPHK1/sphingosine kinase 1-mediated autophagy differs between neurons and SH-SY5Y neuroblastoma cells.
Autophagy 2016 Moruno Manchon JF, Uzor NE, Finkbeiner S, Tsvetkov AS -
Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.
Cellular and molecular neurobiology 2016 Zhang X, Abels ER, Redzic JS, Margulis J, Finkbeiner S, Breakefield XO -
αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.
Human molecular genetics 2016 Oliveira AO, Osmand A, Outeiro TF, Muchowski PJ, Finkbeiner S -
A three-groups model for high-throughput survival screens.
Biometrics 2016 Shaby BA, Skibinski G, Ando M, LaDow ES, Finkbeiner S -
Cross-species translation of the Morris maze for Alzheimer's disease.
The Journal of clinical investigation 2016 Possin KL, Sanchez PE, Anderson-Bergman C, Fernandez R, Kerchner GA, Johnson ET, Davis A, Lo I, Bott NT, Kiely T, Fenesy MC, Miller BL, Kramer JH, Finkbeiner S -
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Autophagy 2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, … -
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.
Annual review of pharmacology and toxicology 2015 Haston KM, Finkbeiner S -
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Scientific reports 2015 Moruno Manchon JF, Uzor NE, Dabaghian Y, Furr-Stimming EE, Finkbeiner S, Tsvetkov AS -
Sequence-Level Analysis of the Major European Huntington Disease Haplotype.
American journal of human genetics 2015 Lee JM, Kim KH, Shin A, Chao MJ, Abu Elneel K, Gillis T, Mysore JS, Kaye JA, Zahed H, Kratter IH, Daub AC, Finkbeiner S, Li H, Roach JC, Goodman N, Hood L, Myers RH, MacDonald ME, Gusella JF -
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1.
Proceedings of the National Academy of Sciences of the United States of America 2015 Barmada SJ, Ju S, Arjun A, Batarse A, Archbold HC, Peisach D, Li X, Zhang Y, Tank EM, Qiu H, Huang EJ, Ringe D, Petsko GA, Finkbeiner S -
Going retro: ancient viral origins of cognition.
Neuron 2015 Campioni MR, Finkbeiner S -
Cell-based screening: extracting meaning from complex data.
Neuron 2015 Finkbeiner S, Frumkin M, Kassner PD -
Dexpramipexole is ineffective in two models of ALS related neurodegeneration.
PloS one 2014 Vieira FG, LaDow E, Moreno A, Kidd JD, Levine B, Thompson K, Gill A, Finkbeiner S, Perrin S -
Potential function for the Huntingtin protein as a scaffold for selective autophagy.
Proceedings of the National Academy of Sciences of the United States of America 2014 Ochaba J, Lukacsovich T, Csikos G, Zheng S, Margulis J, Salazar L, Mao K, Lau AL, Yeung SY, Humbert S, Saudou F, Klionsky DJ, Finkbeiner S, Zeitlin SO, Marsh JL, Housman DE, Thompson LM, Steffan JS -
Targeting the low-hanging fruit of neurodegeneration.
Neurology 2014 Mason AR, Ziemann A, Finkbeiner S -
Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference.
Annals of neurology 2014 Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ, Parkinson's … -
Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.
Frontiers in cellular neuroscience 2014 Margulis J, Finkbeiner S -
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.
Nature chemical biology 2014 Barmada SJ, Serio A, Arjun A, Bilican B, Daub A, Ando DM, Tsvetkov A, Pleiss M, Li X, Peisach D, Shaw C, Chandran S, Finkbeiner S -
Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.
PloS one 2014 Tóth G, Gardai SJ, Zago W, Bertoncini CW, Cremades N, Roy SL, Tambe MA, Rochet JC, Galvagnion C, Skibinski G, Finkbeiner S, Bova M, Regnstrom K, Chiou SS, Johnston J, Callaway K, Anderson JP, Jobling … -
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects.
The Journal of clinical investigation 2014 Qiu H, Lee S, Shang Y, Wang WY, Au KF, Kamiya S, Barmada SJ, Finkbeiner S, Lui H, Carlton CE, Tang AA, Oldham MC, Wang H, Shorter J, Filiano AJ, Roberson ED, Tourtellotte WG, Chen B, Tsai LH, Huang EJ -
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2014 Skibinski G, Nakamura K, Cookson MR, Finkbeiner S -
Executive functions in premanifest Huntington's disease.
Movement disorders : official journal of the Movement Disorder Society 2013 You SC, Geschwind MD, Sha SJ, Apple A, Satris G, Wood KA, Johnson ET, Gooblar J, Feuerstein JS, Finkbeiner S, Kang GA, Miller BL, Hess CP, Kramer JH, Possin KL -
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.
Nature genetics 2013 Kim HJ, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM, Finkbeiner S, Gitler AD, Bonini NM -
PML in the Brain: From Development to Degeneration.
Frontiers in oncology 2013 Korb E, Finkbeiner S -
Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells.
eLife 2013 Sun Y, Dong Z, Jin T, Ang KH, Huang M, Haston KM, Peng J, Zhong TP, Finkbeiner S, Weiss WA, Arkin MR, Jan LY, Guo S -
Startups on the menu.
Nature biotechnology 2013 Finkbeiner S -
Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology.
ACS chemical biology 2013 Zhang C, Lopez MS, Dar AC, Ladow E, Finkbeiner S, Yun CH, Eck MJ, Shokat KM -
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration.
Nature chemical biology 2013 Tsvetkov AS, Arrasate M, Barmada S, Ando DM, Sharma P, Shaby BA, Finkbeiner S -
Targeting H3K4 trimethylation in Huntington disease.
Proceedings of the National Academy of Sciences of the United States of America 2013 Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, Song W, Lau A, Labadorf A, Vogel-Ciernia A, Troncosco J, Ross CA, Bates GP, Krainc D, Sadri-Vakili G, Finkbeiner S, Marsh JL, Housman … -
Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity.
Nature neuroscience 2013 Korb E, Wilkinson CL, Delgado RN, Lovero KL, Finkbeiner S -
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells".
Science translational medicine 2013 Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, Wilmut I, Finkbeiner S,… -
NUB1 snubs huntingtin toxicity.
Nature neuroscience 2013 Aron R, Tsvetkov A, Finkbeiner S -
Longitudinal measures of proteostasis in live neurons: features that determine fate in models of neurodegenerative disease.
FEBS letters 2013 Skibinski G, Finkbeiner S -
Modeling Huntington's disease with induced pluripotent stem cells.
Molecular and cellular neurosciences 2013 Kaye JA, Finkbeiner S -
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy.
Proceedings of the National Academy of Sciences of the United States of America 2013 Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, Carrasco MA, Phatnani HP, Shum C, Wilmut I, Maniatis T, Shaw CE, Finkbeiner S, Chandran S -
Longitudinal imaging and analysis of neurons expressing polyglutamine-expanded proteins.
Methods in molecular biology (Clifton, N.J.) 2013 Tsvetkov AS, Ando DM, Finkbeiner S -
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models.
Nature genetics 2012 Armakola M, Higgins MJ, Figley MD, Barmada SJ, Scarborough EA, Diaz Z, Fang X, Shorter J, Krogan NJ, Finkbeiner S, Farese RV, Gitler AD -
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury.
The Journal of clinical investigation 2012 Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L, Finkbeiner S, Huang EJ, Farese RV -
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.
PloS one 2012 Wray S, Self M, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin… -
Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Sontag EM, Lotz GP, Agrawal N, Tran A, Aron R, Yang G, Necula M, Lau A, Finkbeiner S, Glabe C, Marsh JL, Muchowski PJ, Thompson LM -
Guidelines for the use and interpretation of assays for monitoring autophagy.
Autophagy 2012 Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, Agholme L, Agnello M, Agostinis P, Aguirre-Ghiso JA, Ahn HJ, Ait-Mohamed O, Ait-Si-Ali S, Akematsu T, Akira S, Al-Younes … -
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.
Proceedings of the National Academy of Sciences of the United States of America 2012 Bilican B, Serio A, Barmada SJ, Nishimura AL, Sullivan GJ, Carrasco M, Phatnani HP, Puddifoot CA, Story D, Fletcher J, Park IH, Friedman BA, Daley GQ, Wyllie DJ, Hardingham GE, Wilmut I, Finkbeiner S,… -
Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein.
The Journal of biological chemistry 2012 Nucifora LG, Burke KA, Feng X, Arbez N, Zhu S, Miller J, Yang G, Ratovitski T, Delannoy M, Muchowski PJ, Finkbeiner S, Legleiter J, Ross CA, Poirier MA -
Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure.
Journal of molecular biology 2012 Peters-Libeu C, Miller J, Rutenber E, Newhouse Y, Krishnan P, Cheung K, Hatters D, Brooks E, Widjaja K, Tran T, Mitra S, Arrasate M, Mosquera LA, Taylor D, Weisgraber KH, Finkbeiner S -
High-throughput screening in primary neurons.
Methods in enzymology 2012 Sharma P, Ando DM, Daub A, Kaye JA, Finkbeiner S -
Protein aggregates in Huntington's disease.
Experimental neurology 2011 Arrasate M, Finkbeiner S -
A comprehensive glossary of autophagy-related molecules and processes (2nd edition).
Autophagy 2011 Klionsky DJ, Baehrecke EH, Brumell JH, Chu CT, Codogno P, Cuervo AM, Debnath J, Deretic V, Elazar Z, Eskelinen EL, Finkbeiner S, Fueyo-Margareto J, Gewirtz D, Jäättelä M, Kroemer G, Levine B, Melia TJ… -
Identifying polyglutamine protein species in situ that best predict neurodegeneration.
Nature chemical biology 2011 Miller J, Arrasate M, Brooks E, Libeu CP, Legleiter J, Hatters D, Curtis J, Cheung K, Krishnan P, Mitra S, Widjaja K, Shaby BA, Lotz GP, Newhouse Y, Mitchell EJ, Osmand A, Gray M, Thulasiramin V, … -
Arc in synaptic plasticity: from gene to behavior.
Trends in neurosciences 2011 Korb E, Finkbeiner S -
Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine.
Neuron 2011 Gittis AH, Hang GB, LaDow ES, Shoenfeld LR, Atallah BV, Finkbeiner S, Kreitzer AC -
Drug discovery in Parkinson's disease-Update and developments in the use of cellular models.
International journal of high throughput screening 2011 Skibinski G, Finkbeiner S -
Huntington's Disease.
Cold Spring Harbor perspectives in biology 2011 Finkbeiner S -
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein.
The Journal of biological chemistry 2011 Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, Edwards RH -
A compact beta model of huntingtin toxicity.
The Journal of biological chemistry 2011 Zhang QC, Yeh TL, Leyva A, Frank LG, Miller J, Kim YE, Langen R, Finkbeiner S, Amzel ML, Ross CA, Poirier MA -
Bringing SOD1 into the fold.
Nature neuroscience 2010 Barmada S, Finkbeiner S -
Arc regulates spine morphology and maintains network stability in vivo.
Proceedings of the National Academy of Sciences of the United States of America 2010 Peebles CL, Yoo J, Thwin MT, Palop JJ, Noebels JL, Finkbeiner S -
PolyQ disease: too many Qs, too much function?
Neuron 2010 Kratter IH, Finkbeiner S -
Bridging the Valley of Death of therapeutics for neurodegeneration.
Nature medicine 2010 Finkbeiner S -
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model.
Proceedings of the National Academy of Sciences of the United States of America 2010 Tsvetkov AS, Miller J, Arrasate M, Wong JS, Pleiss MA, Finkbeiner S -
Tau reduction prevents Abeta-induced defects in axonal transport.
Science (New York, N.Y.) 2010 Vossel KA, Zhang K, Brodbeck J, Daub AC, Sharma P, Finkbeiner S, Cui B, Mucke L -
Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, Finkbeiner S -
Conformation sensors that distinguish monomeric proteins from oligomers in live cells.
Chemistry & biology 2010 Ramdzan YM, Nisbet RM, Miller J, Finkbeiner S, Hill AF, Hatters DM -
Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease.
The Journal of biological chemistry 2010 Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, Trottier Y, Richards WG, Osmand A, Paganetti P, Bates GP -
Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010 Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S -
Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease.
Human molecular genetics 2010 Sathasivam K, Lane A, Legleiter J, Warley A, Woodman B, Finkbeiner S, Paganetti P, Muchowski PJ, Wilson S, Bates GP -
Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
Reviews in the neurosciences 2010 Barmada SJ, Finkbeiner S -
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
Neuron 2009 Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S, Steffan JS, Thompson LM, Wetzel R, Yang XW -
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome.
The Journal of cell biology 2009 Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A, Martinez-Vincente M, Arrasate M, O'Rourke JG, Khashwji H, Lukacsovich T, Zhu YZ, Lau AL, Massey A, Hayden MR, Zeitlin SO, … -
High-content screening of primary neurons: ready for prime time.
Current opinion in neurobiology 2009 Daub A, Sharma P, Finkbeiner S -
Protein turnover and inclusion body formation.
Autophagy 2009 Mitra S, Tsvetkov AS, Finkbeiner S -
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.
The Journal of biological chemistry 2009 Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, Finkbeiner S, Patterson PH, Muchowski PJ -
Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.
Human molecular genetics 2009 Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE -
The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2009 Pintchovski SA, Peebles CL, Kim HJ, Verdin E, Finkbeiner S -
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease.
The Journal of biological chemistry 2008 Mitra S, Tsvetkov AS, Finkbeiner S -
The ubiquitin-proteasome pathway in Huntington's disease.
TheScientificWorldJournal 2008 Finkbeiner S, Mitra S -
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.
Neuron 2007 Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L -
RNA decay back in play.
Nature neuroscience 2007 Peebles CL, Finkbeiner S -
NMDA and AMPA receptors: old channels, new tricks.
Trends in neurosciences 2007 Rao VR, Finkbeiner S -
Disease-modifying pathways in neurodegeneration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 Finkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ -
Common threads in neurodegenerative disorders of aging.
Alzheimer's & dementia : the journal of the Alzheimer's Association 2006 Beal MF, Bossy-Wetzel E, Finkbeiner S, Fiskum G, Giasson B, Johnson C, Khachaturian ZS, Lee VM, Nicholls D, Reddy H, Reynolds I, Teplow DB, Thal LJ, Trojanowski JQ, Walsh DM, Wetzel R, Wexler NS, … -
AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc.
Nature neuroscience 2006 Rao VR, Pintchovski SA, Chin J, Peebles CL, Mitra S, Finkbeiner S -
Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006 Bradley J, Carter SR, Rao VR, Wang J, Finkbeiner S -
Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches.
Acta crystallographica. Section F, Structural biology and crystallization communications 2005 Peters-Libeu C, Newhouse Y, Krishnan P, Cheung K, Brooks E, Weisgraber K, Finkbeiner S -
Automated microscope system for determining factors that predict neuronal fate.
Proceedings of the National Academy of Sciences of the United States of America 2005 Arrasate M, Finkbeiner S -
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.
Nature 2004 Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S -
Using antibodies to analyze polyglutamine stretches.
Methods in molecular biology (Clifton, N.J.) 2004 Brooks E, Arrasate M, Cheung K, Finkbeiner SM -
Secrets of a secretase: N-cadherin proteolysis regulates CBP function.
Cell 2003 Rao VR, Finkbeiner S -
An evaluation of specificity in activity-dependent gene expression in neurons.
Progress in neurobiology 2002 Bradley J, Finkbeiner S -
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.
Developmental cell 2002 Humbert S, Bryson EA, Cordelières FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F -
New roles for introns: sites of combinatorial regulation of Ca2+- and cyclic AMP-dependent gene transcription.
Science's STKE : signal transduction knowledge environment 2001 Finkbeiner S -
Calcium regulation of the brain-derived neurotrophic factor gene.
Cellular and molecular life sciences : CMLS 2000 Finkbeiner S -
CREB couples neurotrophin signals to survival messages.
Neuron 2000 Finkbeiner S -
Sending signals from the synapse to the nucleus: possible roles for CaMK, Ras/ERK, and SAPK pathways in the regulation of synaptic plasticity and neuronal growth.
Journal of neuroscience research 1999 Curtis J, Finkbeiner S -
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.
Cell 1998 Saudou F, Finkbeiner S, Devys D, Greenberg ME -
Ca2+ channel-regulated neuronal gene expression.
Journal of neurobiology 1998 Finkbeiner S, Greenberg ME -
To fear or not to fear: what was the question? A potential role for Ras-GRF in memory.
BioEssays : news and reviews in molecular, cellular and developmental biology 1998 Finkbeiner S, Dalva MB -
Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism.
Neuron 1998 Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME -
CREB: a major mediator of neuronal neurotrophin responses.
Neuron 1997 Finkbeiner S, Tavazoie SF, Maloratsky A, Jacobs KM, Harris KM, Greenberg ME -
Spatial features of calcium-regulated gene expression.
BioEssays : news and reviews in molecular, cellular and developmental biology 1997 Finkbeiner S, Greenberg ME -
Ca(2+)-dependent routes to Ras: mechanisms for neuronal survival, differentiation, and plasticity?
Neuron 1996 Finkbeiner S, Greenberg ME -
Glial calcium.
Glia 1993 Finkbeiner SM -
Calcium excitability and oscillations in suprachiasmatic nucleus neurons and glia in vitro.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1992 van den Pol AN, Finkbeiner SM, Cornell-Bell AH -
Calcium waves in astrocytes-filling in the gaps.
Neuron 1992 Finkbeiner S -
Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect.
The American journal of emergency medicine 1991 Renzi R, Finkbeiner S -
Endothelin induces a sustained rise in intracellular calcium in hippocampal astrocytes.
Neuroscience letters 1991 Goldman RS, Finkbeiner SM, Smith SJ -
Ca2+ waves in astrocytes.
Cell calcium 1991 Cornell-Bell AH, Finkbeiner SM -
Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling.
Science (New York, N.Y.) 1990 Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ -
Synthesis and characterization of a series of diarylguanidines that are noncompetitive N-methyl-D-aspartate receptor antagonists with neuroprotective properties.
Proceedings of the National Academy of Sciences of the United States of America 1989 Keana JF, McBurney RN, Scherz MW, Fischer JB, Hamilton PN, Smith SM, Server AC, Finkbeiner S, Stevens CF, Jahr C -
Therapeutic use of magnesium sulfate in selected cases of cerebral ischemia and seizure.
The New England journal of medicine 1988 Goldman RS, Finkbeiner SM -
Applications of quantitative measurements for assessing glutamate neurotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1988 Finkbeiner S, Stevens CF